Efficacy of Extracorporeal Magnetic Stimulation, Pelvic Floor Muscle Exercise, and Combination of Both in Management of Post Radical Prostatectomy Urinary Incontinence
NCT ID: NCT05680168
Last Updated: 2023-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2023-01-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy
NCT07101731
Urinary Incontinence After Radical Prostatectomy
NCT05625048
Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence
NCT02485665
Trial Study of the Efficacy of Intensive Preoperative Pelvic Floor Muscle Training to Decrease Post-prostatectomy Urinary Incontinence
NCT01338584
Additional Effects of Aerobic and Resistance Exercises to Pelvic Floor Muscle Training After Radical Prostatectomy
NCT06126874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Extracorporeal Magnetic stimulation
Group (A): will receive rehabilitation program with exposure to ExMS, Patients will receive regular sessions of electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia). Each session will last for 20 minutes. Patients will receive three weekly sessions for total of 20 sessions starting one month after catheter removal.
Extracorporeal electromagnetic stimulation
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
Group B: Extracorporeal Magnetic stimulation and pelvic floor exercises
Group (B): This group will receive a rehabilitation program depending ExMS with the protocol described above. In addition, this group will be advised for pelvic floor muscle training in serial training sessions with our therapist for PME.
Extracorporeal electromagnetic stimulation
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
Pelvic floor exercises
Pelvic floor muscle training in serial training sessions with our therapist
Group C: Pelvic floor exercises
Group (C): This will be the control group. This group will be advised to do PME only. The pelvic floor exercises will consist of advice to the patients to contract the anal sphincter muscles in successive way as if holding flatus. The pelvic floor muscle training schedule and therapist in group B and group C will be the same.
Pelvic floor exercises
Pelvic floor muscle training in serial training sessions with our therapist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extracorporeal electromagnetic stimulation
Electromagnetic stimulation using Magneto STYM device, (Iskra medical d.o.o, Slovenia).
Pelvic floor exercises
Pelvic floor muscle training in serial training sessions with our therapist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with low to intermediate risk prostate cancer who received chemo or radiotherapy then had salvage surgery
* Patients with urinary incontinence or diagnosed overactive bladder before radical prostatectomy.
* Patients with complicated surgery resulting in anastomotic leak, prolonged catheterisation more than 3 weeks, reinsertion of catheter due to retention of urine.
* Patients who refuse to participate in the clinical trial.
18 Years
80 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamad General Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Albakr
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ambulatory Care Center
Doha, , Qatar
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Albakr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRC0122185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.